Clinical trial

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

NCT02369926

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-11-01

PhasePHASE2

Study timeline

Study start (unknown)2014-11-01Date precision: month

Registry last updated2017-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

Multiple Sclerosis Functional CompositePROCEDURE

Mobile Multiple Sclerosis Functional CompositePROCEDURE

Sponsors & collaborators

Transparency Life Scienceslead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02369926 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.